Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management

• मुख्य लेखकों: K. Chanprapaph (लेखक), V. Vachiramon (लेखक), P. Rattanakaemakorn (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Hindawi Limited, 2014-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Epidermal growth factor inhibitors (EGFRI), the first targeted cancer therapy, are currently an essential treatment for many advance-stage epithelial cancers. These agents have the superior ability to target cancers cells and better safety profile compared to conventional chemotherapies. However, cu...